These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6360815)

  • 1. Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension.
    Mills PR; Rae AP; Farah DA; Russell RI; Lorimer AR; Carter DC
    Gut; 1984 Jan; 25(1):73-8. PubMed ID: 6360815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of a cardioselective and a nonselective beta-blocker on portal hypertension in patients with cirrhosis.
    Hillon P; Lebrec D; Muńoz C; Jungers M; Goldfarb G; Benhamou JP
    Hepatology; 1982; 2(5):528-31. PubMed ID: 7118065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study.
    Lebrec D; Hillon P; Muńoz C; Goldfarb G; Nouel O; Benhamou JP
    Hepatology; 1982; 2(5):523-7. PubMed ID: 6981575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term haemodynamic effects of a 4-week regimen of nipradilol, a new beta-blocker with nitrovasodilating properties, in patients with portal hypertension due to cirrhosis. A comparative study with propranolol.
    Aramaki T; Sekiyama T; Katsuta Y; Kurokawa H; Komeichi H; Tsutsui H; Terada H; Ohsuga M; Satomura K; Okumura H
    J Hepatol; 1992 May; 15(1-2):48-53. PubMed ID: 1354676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portal venous flow in response to acute beta-blocker and vasodilatatory treatment in patients with liver cirrhosis.
    Zoli M; Marchesini G; Brunori A; Cordiani MR; Pisi E
    Hepatology; 1986; 6(6):1248-51. PubMed ID: 2878867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term effects of propranolol on portal venous pressure.
    Garcia-Tsao G; Grace ND; Groszmann RJ; Conn HO; Bermann MM; Patrick MJ; Morse SS; Alberts JL
    Hepatology; 1986; 6(1):101-6. PubMed ID: 3943775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological lowering of portal pressure in normal rats and in experimental liver cirrhosis].
    Altmann O
    Gastroenterol J; 1991; 51(3-4):142-8. PubMed ID: 1811660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension.
    Marshall AJ; Barritt DW; Pocock J; Heaton ST
    Lancet; 1977 Feb; 1(8006):271-4. PubMed ID: 64803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irbesartan plus low-dose propranolol versus low-dose propranolol alone in cirrhosis: a placebo-controlled, double-blind study.
    Schepke M; Wiest R; Flacke S; Heller J; Stoffel-Wagner B; Herold T; Ghauri M; Sauerbruch T
    Am J Gastroenterol; 2008 May; 103(5):1152-8. PubMed ID: 18422814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension.
    Kim JH; Kim JM; Cho YZ; Na JH; Kim HS; Kim HA; Kang HW; Baik SK; Kwon SO; Cha SH; Kim YJ; Kim MY
    Clin Mol Hepatol; 2014 Dec; 20(4):376-83. PubMed ID: 25548744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of prazosin and atenolol on plasma lipids in hypertensive patients.
    Rouffy J; Jaillard J
    Am J Med; 1984 Feb; 76(2A):105-8. PubMed ID: 6702861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effect of spironolactone in liver cirrhosis and propranolol-resistant portal hypertension.
    Sen S; De BK; Biswas PK; Biswas J; Das D; Maity AK
    Indian J Gastroenterol; 2002; 21(4):145-8. PubMed ID: 12385542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nipradilol, a new beta-blocker with vasodilatory properties, in experimental portal hypertension: a comparative haemodynamic study with propranolol.
    Um S; Nishida O; Tokubayashi M; Kimura F; Kita T
    J Gastroenterol Hepatol; 1993; 8(5):414-9. PubMed ID: 8105997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of ketanserin and verapamil or propranolol in patients with alcoholic cirrhosis: search for an additive effect.
    Hadengue A; Moreau R; Cerini R; Koshy A; Lee SS; Lebrec D
    Hepatology; 1989 Jan; 9(1):83-7. PubMed ID: 2908872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study.
    Hobolth L; Bendtsen F; Hansen EF; Møller S
    Dig Liver Dis; 2014 Mar; 46(3):251-6. PubMed ID: 24290869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol and haemodynamic response in cirrhosis.
    Bendtsen F; Henriksen JH; Sørensen TI
    J Hepatol; 1991 Sep; 13(2):144-8. PubMed ID: 1744417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effect of propranolol on portal hypertension in patients with HBsAg-positive cirrhosis.
    Kong CW; Lay CS; Tsai YT; Lee SD; Lai KH; Lo KJ; Chiang BN
    Dig Dis Sci; 1986 Dec; 31(12):1303-6. PubMed ID: 3803132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study.
    Kim MY; Baik SK; Park DH; Lim DW; Kim JW; Kim HS; Kwon SO; Kim YJ; Chang SJ; Lee SS
    Liver Int; 2007 Oct; 27(8):1103-10. PubMed ID: 17845539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monotherapy in mild to moderate hypertension: comparison of hydrochlorothiazide, propranolol and prazosin.
    Inouye I; Massie B; Benowitz N; Simpson P; Loge D; Topic N
    Am J Cardiol; 1984 Jan; 53(3):24A-28A. PubMed ID: 6320622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.